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Background
Nitric oxide (NO) signalling through activation of soluble
guanylyl cyclase (sGC) is key for the physiology of the car-
diovascular and neuronal systems. Discrepancies in sGC
activation and deactivation in vitro vs. in vivo have led to a
search for endogenous factors that regulate sGC or assist
in cellular localization. In our previous work, which identi-
fied Hsp70 as a modulator of sGC, we determined that
protein disulfide isomerase (PDI) bound to an sGC-affinity
matrix [1]. As several studies have reported that thiol oxi-
dants and reductants modulate sGC activity, we sought to
characterize the potential interaction between sGC and
PDI, an enzyme that not only isomerases disulfide bonds
but also regulates some proteins activity via interaction
with its cysteine (Cys) active sites [2,3].
Results
Using protein chemistry and purified sGC and PDI, we
first showed that reduced sGC was modified by oxidized
PDI in non-reducing Western blot and that sGC thiol titer
was altered under these conditions. Moreover a PDI-Flag
resin retains specifically sGC and this complex was
resolved in the presence of a thiol-reductant. These data
suggested that the mechanism of interaction between sGC
and PDI is by mixed-disulfide exchange. In addition,
PDI modulated NO-stimulated sGC activity while a PDI
mutated in its two Cys active sites did not. A relatively
novel method, in situ PLA (proximity ligation assay) estab-
lished that endogenous PDI and sGC also interact in the
CRL 2018 smooth muscle cells suggesting that the inter-
action between sGC and PDI is biologically relevant.
Notably, both a1 and b1 sGC subunits of sGC showed
potential co-localization with PDI [4].
Discussion
These results underlined the significance of redox-thiol
modulation of sGC and support past and current research
showing that certain sGC Cys are necessary for such func-
tions as enzyme activation, dimerization, and desensitiza-
tion by S-nitrosation. A novel Mass Spectrometry analysis
is currently applied to identify sGC Cys disulfide bonds
and combined with mutational analysis and molecular
dynamics simulation should unveil their involvement in
interaction with PDI and their relevance as a new mechan-
ism of sGC modulation.
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